HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,468,006 | +120.1% | 128,679,626 | +115.5% | 5.49% | +34.4% |
| Q2 2023 | $50,184,506 | -16.9% | 59,699,359 | -15.7% | 4.08% | -8.4% |
| Q1 2023 | $60,420,911 | +80366.8% | 70,776,482 | +91298.8% | 4.46% | -12.3% |
| Q4 2022 | $75,088 | -99.9% | 77,437 | -13.1% | 5.08% | -6.0% |
| Q3 2022 | $76,268,000 | -7.0% | 89,152 | -3.4% | 5.41% | -1.4% |
| Q2 2022 | $82,027,000 | +28.9% | 92,289 | +29.2% | 5.48% | +26.7% |
| Q1 2022 | $63,617,000 | – | 71,432 | – | 4.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
| Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
| ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
| Penn Mutual Asset Management | 1,305,000 | $1,137,000 | 1.32% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
| CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
| Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
| Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |